Baillie Gifford & Co
HUM icon

Baillie Gifford & Co’s Humana HUM Stock Holding History

Baillie Gifford & Co’s Portfolio HUM Stock Details HUM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-64
Closed -$31.1K – 363
2023
Q1 		$31.1K Buy
64
+9
+16% +$4.45K ﹤0.01% 310
2022
Q4 		$28.2K Hold
55
– – ﹤0.01% 319
2022
Q3 		$27K Sell
55
-5
-8% -$2.43K ﹤0.01% 313
2022
Q2 		$28K Buy
60
+4
+7% +$1.78K ﹤0.01% 314
2022
Q1 		$24K Hold
56
– – ﹤0.01% 348
2021
Q4 		$26K Hold
56
– – ﹤0.01% 347
2021
Q3 		$22K Sell
56
-2
-3% -$849 ﹤0.01% 358
2021
Q2 		$26K Buy
+58
New +$25.3K ﹤0.01% 330

Other funds holding HUM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Baillie Gifford & Co's HUM Position: Q2 2023 in Review

Baillie Gifford & Co sold out of Humana (HUM) in Q2 2023, closing a stake of 64 shares — an estimated $31.1K sold.

Baillie Gifford & Co first reported a position in HUM in Q2 2021 and held it in 8 quarters. The position peaked at $31.1K in Q1 2023. 1,070 funds tracked by Wall St. Rank hold HUM as of Q2 2023.

  • Baillie Gifford & Co reported no remaining Humana position as of Q2 2023 after selling out during the quarter.
  • Baillie Gifford & Co sold 64 Humana shares in Q2 2023, an estimated $31.1K.
  • Baillie Gifford & Co first reported a position in Humana in Q2 2021 and held it in 8 quarters.
  • Baillie Gifford & Co's Humana position peaked at $31.1K in Q1 2023.
  • 1,070 funds tracked by Wall St. Rank held Humana as of Q2 2023.

Based on Baillie Gifford & Co's 13F filing for Q2 2023, filed 28 Jul 2023.